Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CRL NYSE:DECK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRLCharles River Laboratories International$163.29+0.0%$159.32$91.86▼$230.02$8.04B1.48954,372 shs860,239 shsDECKDeckers Outdoor$119.61+1.2%$105.72$93.72▼$223.98$17.75B0.992.50 million shs2.66 million shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRLCharles River Laboratories International0.00%+1.08%-3.59%+20.50%-17.09%DECKDeckers Outdoor0.00%+9.78%+12.81%+13.30%+353.46%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRLCharles River Laboratories International4.0153 of 5 stars1.15.00.04.72.92.51.9DECKDeckers Outdoor4.7233 of 5 stars3.25.00.02.02.93.32.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRLCharles River Laboratories International 2.27Hold$175.697.60% UpsideDECKDeckers Outdoor 2.42Hold$137.5014.96% UpsideCurrent Analyst Ratings BreakdownLatest DECK and CRL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025CRLCharles River Laboratories InternationalEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$180.00 ➝ $190.008/7/2025CRLCharles River Laboratories InternationalJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$145.00 ➝ $160.008/7/2025CRLCharles River Laboratories InternationalBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$155.00 ➝ $165.007/25/2025DECKDeckers OutdoorRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetStrong-Buy ➝ Strong-Buy$123.00 ➝ $137.007/25/2025DECKDeckers OutdoorTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$130.00 ➝ $145.007/25/2025DECKDeckers OutdoorUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$144.00 ➝ $158.007/25/2025DECKDeckers OutdoorBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$128.00 ➝ $134.007/25/2025DECKDeckers OutdoorWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$90.00 ➝ $100.007/25/2025DECKDeckers OutdoorEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$110.00 ➝ $115.007/25/2025DECKDeckers OutdoorTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform$120.007/25/2025DECKDeckers OutdoorRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$140.00 ➝ $150.00(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRLCharles River Laboratories International$4.05B1.98$21.69 per share7.53$68.26 per share2.39DECKDeckers Outdoor$5.12B3.46$6.84 per share17.49$16.63 per share7.19Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRLCharles River Laboratories International$22.20M-$1.33N/A14.845.21-1.69%15.74%7.09%11/5/2025 (Estimated)DECKDeckers Outdoor$966.09M$6.5218.3518.124.5419.42%40.49%26.95%10/23/2025 (Estimated)Latest DECK and CRL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025CRLCharles River Laboratories International$2.50$3.12+$0.62$1.06$983.76 million$1.03 billion7/24/2025Q1 2026DECKDeckers Outdoor$0.68$0.93+$0.25$0.93$901.45 million$964.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRLCharles River Laboratories InternationalN/AN/AN/AN/AN/ADECKDeckers OutdoorN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRLCharles River Laboratories International0.691.361.10DECKDeckers OutdoorN/A2.942.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRLCharles River Laboratories International98.91%DECKDeckers Outdoor97.79%Insider OwnershipCompanyInsider OwnershipCRLCharles River Laboratories International1.30%DECKDeckers Outdoor0.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRLCharles River Laboratories International20,10049.21 million48.57 millionOptionableDECKDeckers Outdoor5,500148.34 million147.75 millionOptionableDECK and CRL HeadlinesRecent News About These Companies18,600 Shares in Deckers Outdoor Corporation $DECK Purchased by Te Ahumairangi Investment Management LtdAugust 31 at 6:51 AM | marketbeat.comSiren L.L.C. Invests $559,000 in Deckers Outdoor Corporation $DECKAugust 31 at 6:29 AM | marketbeat.comB. Metzler seel. Sohn & Co. AG Purchases 11,352 Shares of Deckers Outdoor Corporation $DECKAugust 31 at 5:40 AM | marketbeat.comComerica Bank Acquires 4,095 Shares of Deckers Outdoor Corporation $DECKAugust 31 at 4:44 AM | marketbeat.comDeckers Outdoor (DECK) Sees 12% Rise in Share Price Over Past WeekAugust 30 at 2:59 PM | uk.finance.yahoo.comDeckers Outdoor Corporation (NYSE:DECK) Receives $137.50 Consensus PT from BrokeragesAugust 30 at 3:55 AM | americanbankingnews.comDeckers (DECK) Ascends While Market Falls: Some Facts to NoteAugust 29 at 6:50 PM | zacks.comTrade Tracker: Stephanie Link buys DeckersAugust 29 at 2:06 PM | youtube.comYCarlson Capital L.P. Buys Shares of 2,500 Deckers Outdoor Corporation $DECKAugust 29 at 8:58 AM | marketbeat.comRB Capital Management LLC Has $1.10 Million Holdings in Deckers Outdoor Corporation $DECKAugust 29 at 7:36 AM | marketbeat.com15,126 Shares in Deckers Outdoor Corporation $DECK Purchased by APG Asset Management N.V.August 29 at 5:06 AM | marketbeat.comDeckers Outdoor Corporation (NYSE:DECK) Receives Average Recommendation of "Hold" from AnalystsAugust 29 at 2:53 AM | marketbeat.comDeckers’ Subsidiary UGG Releases Its Autumn/Winter 2025 CampaignAugust 28 at 12:30 AM | insidermonkey.comUGG fans divided as brand unveils new name following legal battleAugust 28 at 11:23 PM | msn.comPopular shoe company to change name after 50 years following legal battleAugust 28 at 11:23 PM | express.co.ukUgg’s shock new look after losing David and Goliath battle against US rivalAugust 28 at 6:22 PM | thechronicle.com.auTAustralian-owned ‘original’ Ugg manufacturer forcibly rebrandsAugust 28 at 8:21 AM | mumbrella.com.auMIconic shoe brand is changing name after 50 years and customers are 'so upset'August 28 at 8:21 AM | mirror.co.ukMDeckers Outdoor: Losing DTC MomentumAugust 28 at 8:21 AM | seekingalpha.comDeckers Outdoor Stock: Is Wall Street Bullish or Bearish?August 28 at 8:21 AM | finance.yahoo.comEpoch Investment Partners Inc. Has $94.71 Million Position in Deckers Outdoor Corporation $DECKAugust 28 at 8:09 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDECK and CRL Company DescriptionsCharles River Laboratories International NYSE:CRL$163.29 +0.07 (+0.04%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$163.34 +0.05 (+0.03%) As of 08/29/2025 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.Deckers Outdoor NYSE:DECK$119.61 +1.47 (+1.24%) Closing price 08/29/2025 03:59 PM EasternExtended Trading$119.77 +0.16 (+0.13%) As of 08/29/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Deckers Outdoor Corporation, together with its subsidiaries, designs, markets, and distributes footwear, apparel, and accessories for casual lifestyle use and high-performance activities in the United States and internationally. The company offers premium footwear, apparel, and accessories under the UGG brand name; footwear, apparel, and accessories for ultra-runners and athletes under the HOKA brand name; and sandals, shoes, and boots under the Teva brand name. It also provides relaxed casual shoes and sandals under the Sanuk brand name; casual footwear fashion line under the Koolaburra brand name; and footwear under the AHNU brand name. The company sells its products through domestic and international retailers; international distributors; and directly to its consumers through its direct-to-consumer business, which includes e-commerce websites and retail stores. Deckers Outdoor Corporation was founded in 1973 and is headquartered in Goleta, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
